Hinge Health, Inc. (HNGE) · INSIDERData sourcesSEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago
Public companyHinge Health, Inc.
HNGECIK 0001673743
Price$115.76
1 year+155.0%
Disclosed transactions60
Buys / sells0 / 42
Max Insider Score32
Connections with evidence7
HNGE · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 |
| 13 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 5, 2026 | Nov 6, 2026 traded Nov 5, 2026 | +1d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 13 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 5, 2026 | Nov 6, 2026 traded Nov 5, 2026 | +1d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 20 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 4, 2026 | Nov 6, 2026 traded Nov 4, 2026 | +2d | SEC Form 4 | |
| 13 | RERobinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 5, 2026 | Nov 6, 2026 traded Nov 5, 2026 | +1d | SEC Form 4 | |
| 8 | | HNGEHinge Health, Inc. Tax withholding | F | $95K 831 sh | Nov 1, 2026 | Nov 2, 2026 traded Nov 1, 2026 | +1d | SEC Form 4 | |
| 24 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $6.21M 60.0K sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 20 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $9.38M 91.5K sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 9 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $877K 8,642 sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 24 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $4.16M 39.9K sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Oct 12, 2026 | Oct 13, 2026 traded Oct 12, 2026 | +1d | SEC Form 4 | |
| 0 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 4,100 sh | Oct 6, 2026 | Oct 7, 2026 traded Oct 6, 2026 | +1d | SEC Form 4 | |
| 21 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $411K 4,100 sh | Oct 6, 2026 | Oct 7, 2026 traded Oct 6, 2026 | +1d | SEC Form 4 | |
| 0 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 4,100 sh | Oct 6, 2026 | Oct 7, 2026 traded Oct 6, 2026 | +1d | SEC Form 4 | |
| 9 | | HNGEHinge Health, Inc. Grant or award | A | $16K 175 sh | Oct 5, 2026 | Oct 6, 2026 traded Oct 5, 2026 | +1d | SEC Form 4 | |
| 8 | | HNGEHinge Health, Inc. Tax withholding | F | $81K 831 sh | Oct 1, 2026 | Oct 1, 2026 traded Oct 1, 2026 | +0d | SEC Form 4 | |
| 24 | | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $2.18M 23.1K sh | Sep 21, 2026 | Sep 23, 2026 traded Sep 21, 2026 | +2d | SEC Form 4 | |
| 18 | | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $76K 800 sh | Sep 21, 2026 | Sep 23, 2026 traded Sep 21, 2026 | +2d | SEC Form 4 | |
| 21 | | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $846K 9,065 sh | Sep 21, 2026 | Sep 23, 2026 traded Sep 21, 2026 | +2d | SEC Form 4 | |
| 21 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $1.52M 16.5K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 29 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $3.15M 33.5K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 21 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $1.07M 11.7K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 25 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $5.22M 56.2K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 29 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $2.77M 29.3K sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 11 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $249K 2,800 sh | Sep 14, 2026 | Sep 15, 2026 traded Sep 14, 2026 | +1d | SEC Form 4 | |
| 21 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $4.01M 45.5K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 29 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $6.57M 73.2K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 14 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $504K 5,795 sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 29 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $1.06M 11.7K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 32 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $10.09M 113.7K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 0 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 250.0K sh | Sep 11, 2026 | Sep 14, 2026 traded Sep 11, 2026 | +3d | SEC Form 4 | |
| 25 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $2.19M 24.6K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 0 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Gift · 10b5-1 plan | G | — 45.0K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 25 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $3.85M 42.7K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 18 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $652K 7,171 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 11 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 1,100 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 29 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $5.23M 58.1K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 4 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 25 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $3.29M 37.3K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 21 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $2.15M 24.4K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 0 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 145.0K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 11 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,630 sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 0 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 145.0K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 4 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 25 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $1.61M 17.7K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 25 | PAPerez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $3.14M 35.3K sh | Sep 10, 2026 | Sep 11, 2026 traded Sep 10, 2026 | +1d | SEC Form 4 | |
| 12 | WBWardi Teddie BenjaminDirector | HNGEHinge Health, Inc. Other acquisition or disposition | J | — 4,637 sh | Aug 10, 2026 | Aug 12, 2026 traded Aug 10, 2026 | +2d | SEC Form 4 | |
| 9 | | HNGEHinge Health, Inc. Grant or award | A | $16K 246 sh | Jul 5, 2026 | Jul 7, 2026 traded Jul 5, 2026 | +2d | SEC Form 4 | |
| 13 | MIMecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 741 sh | Jul 1, 2026 | Jul 2, 2026 traded Jul 1, 2026 | +1d | SEC Form 4 | |
Director, Exec. Chairman & Co-Founder · Mar 10, 2026